Isifo esibi esiyingozi, esichaphazela inkqubo ye-lymphism ngokubambisana namalungu angaphakathi, kuthiwa yi-lymphosarcoma. Njengomthetho, abagula nabantu baluphele, emva kweminyaka engama-50, ngamanye amaxesha i-tumor ifunyanwe kwabasetyhini abavuthiweyo. Kwonyango, kubalulekile kwinqanaba le-lymphosarcoma elalifunyenwe-unyango lweempawu kunye nokuxeliswa kwe-pathology kuxhomekeke ekufikeleleni kwamanyathelo athathwe.
Iimpawu eziqhelekileyo ze-lymphosarcoma
Kukho iintlobo ezininzi kunye neefom zomhlaza ochazwe, ngamnye obonakaliswa yimbonakalo ethile yekliniki. Imiqondiso eqhelekileyo ye-lymphosarcoma yile:
- ukujuluka okukhulu ebusuku;
- ukulahleka kwesisindo;
- ukunciphisa okanye ukungabikho kokutya kwesantya;
- umkhuhlane wexesha;
- ukhathala okwandisiweyo;
- ukwanda rhoqo kwiqondo lokushisa komzimba ukuya kwiinkcazo ze-subfebrile.
Unyango lwe lymphosarcoma
Indlela yokwenza utywala yinkqubo ephuhliswayo ngokuhambelana nesigaba se-tumor.
Kwinqanaba eli-1 neli-2 lophuhliso lwesifo, unyango lweziyobisi lucetyiswa ngokudibanisa ne-radiotherapy. La machiza alandelayo asetyenziswa:
- Prednisolone ;
- Onkawin;
- Cyclophosphamide;
- Doxarubicin.
Kanye kunye nokuthatha imishanguzo, i-tumor ixiliswe, i-dose (iyonke) yemisebe efunyenwe imalunga ne-45-46 Grey, eqokelela kwikhosi yeeveki ezintandathu.
Ulwaphulo lwe-radiation aluphumelelanga kwizigaba 3 no-4, ngoko ke kuphela
Ngamanye amaxesha, ukuba i-tumor isendaweni yendawo, uncedo lokungenelela lusetyenziswa. Ukusebenza akubandakanyi kuphela ukususwa kwe-pathological accumulation of cells, kodwa nalo lonke iqumrhu elichaphazelekayo.
Ukuxela nge-lymphosarcoma
Amanyathelo okuqala okuphuhlisa i-tumor ngokuxhaphaka ngokukhawuleza ayaphiliswa ngempumelelo kwi-85-100% yamatyala. Amanqanaba okugqibela okuqhubela phambili, kunye nokuveliswa kwenkqubo ye-oncological, i-forecast is a disable.